| Product Type | Impurity Standards |
| CAT. No. | MRL-I32019 |
| CAS. No. | 1246819-59-9 |
| Mol. Formula | C29H31N7O |
| Mol. Weight | 493.61 |
| Synonyms | Imatinib Meta-methyl-piperazine Impurity |
| Chemical Name | 3-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-pyridinyl)-2-pyrimidinylamino]phenyl]benzamide |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In stock |
Imatinib Meta-MPM Impurity with CAS No: 1246819-59-9 is an impurity standard of Imatinib. Imatinib is marketed under the brand name Gleevec (or Glivec) and targeted cancer therapy medication used to treat certain types of cancer. Imatinib is belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by inhibiting specific enzymes called tyrosine kinases that are involved in the growth and spread of cancer cells. Imatinib has revolutionized the treatment of certain cancers and has shown remarkable effectiveness in improving outcomes for patients with these conditions. Buy high quality Imatinib Meta-MPM Impurity from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Imatinib Meta-MPM Impurity